Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evofem Biosciences (EVFM)
OTHER OTC:EVFM
RESEARCH TOOLSreports
Holding EVFM?
Track your performance easily
EVFM Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.05
Previous CloseN/A
Volume1.62M
Average Volume (3M)422.97K
Market Cap
$983.22K
Enterprise Value$49.71M
Total Cash (Recent Filing)$11.48M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.09
Next Earnings
May 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding100,328,690
10 Day Avg. Volume498,072
30 Day Avg. Volume422,971
Standard Deviation0.41
R-Squared0.01
Alpha-0.12
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.06
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio2.50
Enterprise Value/Market Cap50.56
Enterprise Value/Revenue2.67
Enterprise Value/Gross Profit4.25
Enterprise Value/Ebitda-9.66
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Evofem Biosciences News
PremiumCompany Announcements
Evofem Biosciences Reports Q3 2024 Financial Results
PremiumCompany Announcements
Evofem Biosciences Gains Support for Aditxt Merger
PremiumCompany Announcements
Evofem Biosciences Faces Merger and Credit Challenges
PremiumCompany Announcements
Evofem Biosciences Expands Global Reach and Secures Funding
Options Prices
Currently, No data available
---
Ownership Overview
EVFM FAQ
What was Evofem Biosciences’s price range in the past 12 months?
Evofem Biosciences lowest stock price was <$0.01 and its highest was $0.05 in the past 12 months.
What is Evofem Biosciences’s market cap?
Evofem Biosciences’s market cap is $983.22K.
When is Evofem Biosciences’s upcoming earnings report date?
Evofem Biosciences’s upcoming earnings report date is May 07, 2025 which is in 112 days.
How were Evofem Biosciences’s earnings last quarter?
Evofem Biosciences released its earnings results on Nov 14, 2024. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.02.
Is Evofem Biosciences overvalued?
According to Wall Street analysts Evofem Biosciences’s price is currently Overvalued.
Does Evofem Biosciences pay dividends?
Evofem Biosciences does not currently pay dividends.
What is Evofem Biosciences’s EPS estimate?
Evofem Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Evofem Biosciences have?
Evofem Biosciences has 100,328,690 shares outstanding.
What happened to Evofem Biosciences’s price movement after its last earnings report?
Evofem Biosciences reported an EPS of -$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Evofem Biosciences?
Currently, no hedge funds are holding shares in EVFM
---
Company Description
Evofem Biosciences
Evofem Biosciences, Inc. develops therapeutic solutions to meet sexual and reproductive health needs of women. Its product include Amphora Contraceptive for the prevention of pregnancy, antimicrobial drug product for the prevention of sexually transmitted infections and Antimicrobial Drug product to prevent the reoccurrence of bacterial vaginosis. The company was founded in 2007 and is headquartered in San Diego, CA.
---
Technical Analysis
Aytu BioScience
―
Anixa Biosciences
―
BioVie
―
Cyclacel Pharmaceuticals
―
Genprex
―
Oragenics
―
---